SK Biopharmaceuticals Oxadiazole Epilepsy Treatment Patent EP3854788A1
Summary
The European Patent Office published patent application EP3854788A1 for SK Biopharmaceuticals' oxadiazole derivatives used in the treatment of epilepsy. The patent covers heterocyclic compounds classified under C07D271/10 with pharmaceutical applications (A61P25/08, A61K31/4245). The patent lists 16 inventors and designates 32 European states including all major EU markets.
What changed
The EPO published patent EP3854788A1 granting SK Biopharmaceuticals exclusive rights to oxadiazole derivatives for epilepsy treatment. The patent covers compounds under IPC classification C07D271/10 and pharmaceutical composition claims (A61K31/4245) for treating epilepsy (A61P25/08).
Pharmaceutical companies developing competing epilepsy treatments in Europe should assess freedom-to-operate implications. Generic manufacturers and biosimilar developers may need to design around this patent or seek licensing arrangements for any overlapping compound claims.
What to do next
- Monitor patent landscape for epilepsy treatment developments
- Review freedom-to-operate for any competing oxadiazole-based therapies in Europe
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF EPILEPSY
Publication EP3854788A1 Kind: A1 Apr 01, 2026
Applicants
SK Biopharmaceuticals Co., Ltd.
Inventors
RYU, Choon Ho, HAN, Min Soo, YOON, Yeo Jin, KIM, Yu Jin, LEE, Ka Eun, LEE, Ju Young, JUNG, Myung Jin, BAEK, Eun Hee, SHIN, Yu Jin, CHOI, Eun Ju, KANG, Young Soon, KIM, Yong Soo, SONG, Yea Mi, KIM, Jin Sung, LIM, Hee Jeong
IPC Classifications
C07D 271/10 20060101AFI20220512BHEP C07D 271/06 20060101ALI20220512BHEP A61P 25/08 20060101ALI20220512BHEP A61K 31/4245 20060101ALI20220512BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.